Report Detail
Global (United States, European Union and China) Active Transdermal Drug Delivery Device Market Research Report 2019-2025
- RnM3348110 |
- 23 April, 2019 |
- Global |
- 111 Pages |
- QYResearch |
- Other
In 2019, the market size of Active Transdermal Drug Delivery Device is million US$ and it will reach million US$ in 2025, growing at a CAGR of from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Active Transdermal Drug Delivery Device.
This report studies the global market size of Active Transdermal Drug Delivery Device, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Active Transdermal Drug Delivery Device production, revenue, market share and growth rate for each key company, and also covers the breakdown data (production, consumption, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
Novartis AG
Noven Pharmaceuticals, Inc.
Transdermal Corp.
Johnson & Johnson (Janssen Pharmaceuticals Inc.)
Mylan N.V.
3M
Actavis, Inc.
Bayer AG
Boehringer Ingelheim GmbH
Corium International, Inc.
Echo Therapeutics, Inc.
GlaxoSmithKline plc
Market Segment by Product Type
Patches
Gels
Market Segment by Application
Clinic
Hospital
Home Use
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Active Transdermal Drug Delivery Device status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Active Transdermal Drug Delivery Device manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Active Transdermal Drug Delivery Device are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Table of Contents
1 Report Overview
- 1.1 Research Scope
- 1.2 Major Manufacturers Covered in This Report
- 1.3 Market Segment by Type
- 1.3.1 Global Active Transdermal Drug Delivery Device Market Size Growth Rate by Type (2019-2025)
- 1.3.2 Patches
- 1.3.3 Gels
- 1.4 Market Segment by Application
- 1.4.1 Global Active Transdermal Drug Delivery Device Market Share by Application (2019-2025)
- 1.4.2 Clinic
- 1.4.3 Hospital
- 1.4.4 Home Use
- 1.5 Study Objectives
- 1.6 Years Considered
2 Global Growth Trends
- 2.1 Production and Capacity Analysis
- 2.1.1 Global Active Transdermal Drug Delivery Device Production Value 2014-2025
- 2.1.2 Global Active Transdermal Drug Delivery Device Production 2014-2025
- 2.1.3 Global Active Transdermal Drug Delivery Device Capacity 2014-2025
- 2.1.4 Global Active Transdermal Drug Delivery Device Marketing Pricing and Trends
- 2.2 Key Producers Growth Rate (CAGR) 2019-2025
- 2.2.1 Global Active Transdermal Drug Delivery Device Market Size CAGR of Key Regions
- 2.2.2 Global Active Transdermal Drug Delivery Device Market Share of Key Regions
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
3 Market Share by Manufacturers
- 3.1 Capacity and Production by Manufacturers
- 3.1.1 Global Active Transdermal Drug Delivery Device Capacity by Manufacturers
- 3.1.2 Global Active Transdermal Drug Delivery Device Production by Manufacturers
- 3.2 Revenue by Manufacturers
- 3.2.1 Active Transdermal Drug Delivery Device Revenue by Manufacturers (2014-2019)
- 3.2.2 Active Transdermal Drug Delivery Device Revenue Share by Manufacturers (2014-2019)
- 3.2.3 Global Active Transdermal Drug Delivery Device Market Concentration Ratio (CR5 and HHI)
- 3.3 Active Transdermal Drug Delivery Device Price by Manufacturers
- 3.4 Key Manufacturers Active Transdermal Drug Delivery Device Plants/Factories Distribution and Area Served
- 3.5 Date of Key Manufacturers Enter into Active Transdermal Drug Delivery Device Market
- 3.6 Key Manufacturers Active Transdermal Drug Delivery Device Product Offered
- 3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
- 4.1 Production and Production Value for Each Type
- 4.1.1 Patches Production and Production Value (2014-2019)
- 4.1.2 Gels Production and Production Value (2014-2019)
- 4.2 Global Active Transdermal Drug Delivery Device Production Market Share by Type
- 4.3 Global Active Transdermal Drug Delivery Device Production Value Market Share by Type
- 4.4 Active Transdermal Drug Delivery Device Ex-factory Price by Type
5 Market Size by Application
- 5.1 Overview
- 5.2 Global Active Transdermal Drug Delivery Device Consumption by Application
6 Production by Regions
- 6.1 Global Active Transdermal Drug Delivery Device Production (History Data) by Regions 2014-2019
- 6.2 Global Active Transdermal Drug Delivery Device Production Value (History Data) by Regions
- 6.3 United States
- 6.3.1 United States Active Transdermal Drug Delivery Device Production Growth Rate 2014-2019
- 6.3.2 United States Active Transdermal Drug Delivery Device Production Value Growth Rate 2014-2019
- 6.3.3 Key Players in United States
- 6.3.4 United States Active Transdermal Drug Delivery Device Import & Export
- 6.4 European Union
- 6.4.1 European Union Active Transdermal Drug Delivery Device Production Growth Rate 2014-2019
- 6.4.2 European Union Active Transdermal Drug Delivery Device Production Value Growth Rate 2014-2019
- 6.4.3 Key Players in European Union
- 6.4.4 European Union Active Transdermal Drug Delivery Device Import & Export
- 6.5 China
- 6.5.1 China Active Transdermal Drug Delivery Device Production Growth Rate 2014-2019
- 6.5.2 China Active Transdermal Drug Delivery Device Production Value Growth Rate 2014-2019
- 6.5.3 Key Players in China
- 6.5.4 China Active Transdermal Drug Delivery Device Import & Export
- 6.6 Rest of World
- 6.6.1 Japan
- 6.6.2 Korea
- 6.6.3 India
- 6.6.4 Southeast Asia
7 Active Transdermal Drug Delivery Device Consumption by Regions
- 7.1 Global Active Transdermal Drug Delivery Device Consumption (History Data) by Regions
- 7.2 United States
- 7.2.1 United States Active Transdermal Drug Delivery Device Consumption by Type
- 7.2.2 United States Active Transdermal Drug Delivery Device Consumption by Application
- 7.3 European Union
- 7.3.1 European Union Active Transdermal Drug Delivery Device Consumption by Type
- 7.3.2 European Union Active Transdermal Drug Delivery Device Consumption by Application
- 7.4 China
- 7.4.1 China Active Transdermal Drug Delivery Device Consumption by Type
- 7.4.2 China Active Transdermal Drug Delivery Device Consumption by Application
- 7.5 Rest of World
- 7.5.1 Rest of World Active Transdermal Drug Delivery Device Consumption by Type
- 7.5.2 Rest of World Active Transdermal Drug Delivery Device Consumption by Application
- 7.5.1 Japan
- 7.5.2 Korea
- 7.5.3 India
- 7.5.4 Southeast Asia
8 Company Profiles
- 8.1 Novartis AG
- 8.1.1 Novartis AG Company Details
- 8.1.2 Company Description and Business Overview
- 8.1.3 Production and Revenue of Active Transdermal Drug Delivery Device
- 8.1.4 Active Transdermal Drug Delivery Device Product Introduction
- 8.1.5 Novartis AG Recent Development
- 8.2 Noven Pharmaceuticals, Inc.
- 8.2.1 Noven Pharmaceuticals, Inc. Company Details
- 8.2.2 Company Description and Business Overview
- 8.2.3 Production and Revenue of Active Transdermal Drug Delivery Device
- 8.2.4 Active Transdermal Drug Delivery Device Product Introduction
- 8.2.5 Noven Pharmaceuticals, Inc. Recent Development
- 8.3 Transdermal Corp.
- 8.3.1 Transdermal Corp. Company Details
- 8.3.2 Company Description and Business Overview
- 8.3.3 Production and Revenue of Active Transdermal Drug Delivery Device
- 8.3.4 Active Transdermal Drug Delivery Device Product Introduction
- 8.3.5 Transdermal Corp. Recent Development
- 8.4 Johnson & Johnson (Janssen Pharmaceuticals Inc.)
- 8.4.1 Johnson & Johnson (Janssen Pharmaceuticals Inc.) Company Details
- 8.4.2 Company Description and Business Overview
- 8.4.3 Production and Revenue of Active Transdermal Drug Delivery Device
- 8.4.4 Active Transdermal Drug Delivery Device Product Introduction
- 8.4.5 Johnson & Johnson (Janssen Pharmaceuticals Inc.) Recent Development
- 8.5 Mylan N.V.
- 8.5.1 Mylan N.V. Company Details
- 8.5.2 Company Description and Business Overview
- 8.5.3 Production and Revenue of Active Transdermal Drug Delivery Device
- 8.5.4 Active Transdermal Drug Delivery Device Product Introduction
- 8.5.5 Mylan N.V. Recent Development
- 8.6 3M
- 8.6.1 3M Company Details
- 8.6.2 Company Description and Business Overview
- 8.6.3 Production and Revenue of Active Transdermal Drug Delivery Device
- 8.6.4 Active Transdermal Drug Delivery Device Product Introduction
- 8.6.5 3M Recent Development
- 8.7 Actavis, Inc.
- 8.7.1 Actavis, Inc. Company Details
- 8.7.2 Company Description and Business Overview
- 8.7.3 Production and Revenue of Active Transdermal Drug Delivery Device
- 8.7.4 Active Transdermal Drug Delivery Device Product Introduction
- 8.7.5 Actavis, Inc. Recent Development
- 8.8 Bayer AG
- 8.8.1 Bayer AG Company Details
- 8.8.2 Company Description and Business Overview
- 8.8.3 Production and Revenue of Active Transdermal Drug Delivery Device
- 8.8.4 Active Transdermal Drug Delivery Device Product Introduction
- 8.8.5 Bayer AG Recent Development
- 8.9 Boehringer Ingelheim GmbH
- 8.9.1 Boehringer Ingelheim GmbH Company Details
- 8.9.2 Company Description and Business Overview
- 8.9.3 Production and Revenue of Active Transdermal Drug Delivery Device
- 8.9.4 Active Transdermal Drug Delivery Device Product Introduction
- 8.9.5 Boehringer Ingelheim GmbH Recent Development
- 8.10 Corium International, Inc.
- 8.10.1 Corium International, Inc. Company Details
- 8.10.2 Company Description and Business Overview
- 8.10.3 Production and Revenue of Active Transdermal Drug Delivery Device
- 8.10.4 Active Transdermal Drug Delivery Device Product Introduction
- 8.10.5 Corium International, Inc. Recent Development
- 8.11 Echo Therapeutics, Inc.
- 8.12 GlaxoSmithKline plc
9 Market Forecast
- 9.1 Global Market Size Forecast
- 9.1.1 Global Active Transdermal Drug Delivery Device Capacity, Production Forecast 2019-2025
- 9.1.2 Global Active Transdermal Drug Delivery Device Production Value Forecast 2019-2025
- 9.2 Market Forecast by Regions
- 9.2.1 Global Active Transdermal Drug Delivery Device Production and Value Forecast by Regions 2019-2025
- 9.2.2 Global Active Transdermal Drug Delivery Device Consumption Forecast by Regions 2019-2025
- 9.3 United States
- 9.3.1 Production and Value Forecast in United States
- 9.3.2 Consumption Forecast in United States
- 9.4 European Union
- 9.4.1 Production and Value Forecast in European Union
- 9.4.2 Consumption Forecast in European Union
- 9.5 China
- 9.5.1 Production and Value Forecast in China
- 9.5.2 Consumption Forecast in China
- 9.6 Rest of World
- 9.6.1 Japan
- 9.6.2 Korea
- 9.6.3 India
- 9.6.4 Southeast Asia
- 9.7 Forecast by Type
- 9.7.1 Global Active Transdermal Drug Delivery Device Production Forecast by Type
- 9.7.2 Global Active Transdermal Drug Delivery Device Production Value Forecast by Type
- 9.8 Consumption Forecast by Application
10 Value Chain and Sales Channels Analysis
- 10.1 Value Chain Analysis
- 10.2 Sales Channels Analysis
- 10.2.1 Active Transdermal Drug Delivery Device Sales Channels
- 10.2.2 Active Transdermal Drug Delivery Device Distributors
- 10.3 Active Transdermal Drug Delivery Device Customers
11 Opportunities & Challenges, Threat and Affecting Factors
- 11.1 Market Opportunities
- 11.2 Market Challenges
- 11.3 Porter's Five Forces Analysis
12 Key Findings
13 Appendix
- 13.1 Research Methodology
- 13.1.1 Methodology/Research Approach
- 13.1.1.1 Research Programs/Design
- 13.1.1.2 Market Size Estimation
- 13.1.1.3 Market Breakdown and Data Triangulation
- 13.1.2 Data Source
- 13.1.2.1 Secondary Sources
- 13.1.2.2 Primary Sources
- 13.1.1 Methodology/Research Approach
- 13.2 Author Details
Summary:
Get latest Market Research Reports on Active Transdermal Drug Delivery Device. Industry analysis & Market Report on Active Transdermal Drug Delivery Device is a syndicated market report, published as Global (United States, European Union and China) Active Transdermal Drug Delivery Device Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Active Transdermal Drug Delivery Device market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
